GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biotage AB (OTCPK:BITGF) » Definitions » Cyclically Adjusted PS Ratio

BITGF (Biotage AB) Cyclically Adjusted PS Ratio : 5.99 (As of May. 16, 2025)


View and export this data going back to 2010. Start your Free Trial

What is Biotage AB Cyclically Adjusted PS Ratio?

As of today (2025-05-16), Biotage AB's current share price is $14.565. Biotage AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was $2.43. Biotage AB's Cyclically Adjusted PS Ratio for today is 5.99.

The historical rank and industry rank for Biotage AB's Cyclically Adjusted PS Ratio or its related term are showing as below:

BITGF' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 4.33   Med: 12.09   Max: 23.25
Current: 7

During the past years, Biotage AB's highest Cyclically Adjusted PS Ratio was 23.25. The lowest was 4.33. And the median was 12.09.

BITGF's Cyclically Adjusted PS Ratio is ranked worse than
80.13% of 478 companies
in the Medical Devices & Instruments industry
Industry Median: 2.23 vs BITGF: 7.00

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Biotage AB's adjusted revenue per share data for the three months ended in Mar. 2025 was $0.474. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $2.43 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Biotage AB Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Biotage AB's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotage AB Cyclically Adjusted PS Ratio Chart

Biotage AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.65 20.60 11.61 7.28 8.01

Biotage AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.69 8.49 9.56 8.01 4.73

Competitive Comparison of Biotage AB's Cyclically Adjusted PS Ratio

For the Medical Instruments & Supplies subindustry, Biotage AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biotage AB's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biotage AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Biotage AB's Cyclically Adjusted PS Ratio falls into.


;
;

Biotage AB Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Biotage AB's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=14.565/2.43
=5.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biotage AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Biotage AB's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.474/132.8245*132.8245
=0.474

Current CPI (Mar. 2025) = 132.8245.

Biotage AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 0.277 99.995 0.368
201509 0.277 100.228 0.367
201512 0.307 100.276 0.407
201603 0.294 100.751 0.388
201606 0.303 101.019 0.398
201609 0.303 101.138 0.398
201612 0.301 102.022 0.392
201703 0.321 102.022 0.418
201706 0.350 102.752 0.452
201709 0.343 103.279 0.441
201712 0.348 103.793 0.445
201803 0.390 103.962 0.498
201806 0.414 104.875 0.524
201809 0.401 105.679 0.504
201812 0.401 105.912 0.503
201903 0.410 105.886 0.514
201906 0.460 106.742 0.572
201909 0.447 107.214 0.554
201912 0.469 107.766 0.578
202003 0.432 106.563 0.538
202006 0.419 107.498 0.518
202009 0.455 107.635 0.561
202012 0.546 108.296 0.670
202103 0.504 108.360 0.618
202106 0.553 108.928 0.674
202109 0.540 110.338 0.650
202112 0.570 112.486 0.673
202203 0.610 114.825 0.706
202206 0.595 118.384 0.668
202209 0.555 122.296 0.603
202212 0.559 126.365 0.588
202303 0.521 127.042 0.545
202306 0.546 129.407 0.560
202309 0.506 130.224 0.516
202312 0.783 131.912 0.788
202403 0.576 132.205 0.579
202406 0.600 132.716 0.600
202409 0.598 132.304 0.600
202412 0.661 132.987 0.660
202503 0.474 132.825 0.474

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Biotage AB  (OTCPK:BITGF) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Biotage AB Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Biotage AB's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotage AB Business Description

Traded in Other Exchanges
Address
Vimpelgatan 5, Box 8, Uppsala, SWE, 751 03
Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. Its customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research, and contract manufacturers as well as clinical, forensic, and academic laboratories in addition to organizations focused on food safety, clean water, and environmental sustainability. It serves three geographic markets: The Americas, APAC (Asia-Pacific,) and EMEA (Europe, Middle East & Africa). The company's product areas include Small Molecules & Synthetic Therapeutics, Biologics & Therapeutics, Scale-Up, Diagnostics, Analytical Testing, and Water & Environmental Testing.

Biotage AB Headlines

From GuruFocus

Biotage AB (publ) appoints new CFO

By PRNewswire PRNewswire 07-01-2021

Biotage - Change in number of shares and votes

By PRNewswire PRNewswire 10-29-2021

Biotage AB (publ) Interim report January-September 2020

By PRNewswire PRNewswire 11-05-2020

Biotage AB (publ) publishes new Financial Goals

By PRNewswire PRNewswire 03-14-2022

Biotage AB (publ) Year-End report January - December 2020

By PRNewswire PRNewswire 02-12-2021

Q4 2024 Biotage AB Earnings Call Transcript

By GuruFocus News 02-20-2025

Biotage AB (publ) Interim report January - September 2021

By PRNewswire PRNewswire 10-28-2021